Trials / Unknown
UnknownNCT04852835
Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Vaccination remains the main promising measure to fight against the COVID-19 pandemic. The presumed efficacy of the vaccines is quite remarkable since it varies between 62 and 95%. There is increasing evidence that sex-specific effects may lead to different outcomes of vaccine safety and efficacy. However, sex-disaggregated data after COVID-19 vaccine are lacking. The first purpose of the study is to determine antibody titers against SARS-CoV-2 spike after COVID-19 vaccination. The secondary purpose is to identify predictor factors of immune response including age, gender and biological factors.
Conditions
Timeline
- Start date
- 2021-04-30
- Primary completion
- 2023-12-01
- Completion
- 2023-12-31
- First posted
- 2021-04-21
- Last updated
- 2023-12-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04852835. Inclusion in this directory is not an endorsement.